Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease.

Brain : a journal of neurology - 1 Sept 1999

Harris G J, Codori A M, Lewis R F, Schmidt E, Bedi A, Brandt J

Abstract excerpt

The aim of this study was to examine basal ganglia volumes and regional cerebral blood flow in asymptomatic subjects at-risk for Huntington's disease who had undergone genetic testing. We determined which measures were the best 'markers' for the presence of the mutation and for the onset of symptoms. Twenty subjects who were Huntington's disease gene mutation-positive and 24 Huntington's disease gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Basal Ganglia
Share to Black People
Share to Cerebrovascular Circulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Huntington Disease

Share to Nuclear Family

Share to Regional Blood Flow

Share to Tomography, Emission-Computed, Single-Photon

Share to Trinucleotide Repeats

Source

Identifiers

PMID: 10468506
DOI: 10.1093/brain/122.9.1667

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease.PMID 10468506Read ↗

Basal ganglia volume and proximity to onset in presymptomatic Huntington disease.Semantic proximity Read ↗

Huntingtonʼs diseaseSemantic proximity Read ↗

Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysisSemantic proximity Read ↗

Molecular Imaging Markers to Track Huntington’s Disease PathologySemantic proximity Read ↗

Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington’s diseaseSemantic proximity Read ↗

Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease.Semantic proximity Read ↗

Striatal and white matter predictors of estimated diagnosis for Huntington disease.Semantic proximity Read ↗

Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease.Semantic proximity Read ↗

Timing of selective basal ganglia white matter loss in Huntington’s diseaseSemantic proximity Read ↗

Decreased Metabolism in the Cerebral Cortex in Early-Stage Huntington's Disease: A Possible Biomarker of Disease Progression?Semantic proximity Read ↗

Molecular Imaging of Huntington's Disease.Semantic proximity Read ↗

Huntingtin silencing delays onset and slows progression of Huntington’s disease: a biomarker studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.